Suppr超能文献

[肝十二指肠韧带骨骼化的肝门胆管癌根治性肝切除术]

[Partial hepatectomy with skeletonization of the hepatoduodenal ligament for hilar cholangiocarcinoma].

作者信息

Jiang Xiao-qing, Zhang Bai-he, Yi Bin, Chen Han, Wu Meng-chao

机构信息

Department of Biliary Surgery, Eastern Hepatobiliary Surgical Hospital, Second Military Medical University, Shanghai 200438, China.

出版信息

Zhonghua Wai Ke Za Zhi. 2004 Feb 22;42(4):210-2.

Abstract

OBJECTIVE

To sum up author's experience and to define the role of partial hepatectomy with skeletonization resection in the treatment of hilar cholangiocarcinoma.

METHODS

Between January 1999 and December 2001, 67 patients underwent exploration in our hospital. The clinical records of these patients were reviewed.

RESULTS

Sixty-five (97%) patients underwent surgical resection. Forty-nine patients (73%) had curative resection [22 skeletonization resection (SR), and the other 27 undergone SR combined with partial hepatectomy]. According to the Bismuth-Corlett classification, tumors were classified into four types. SR was performed in type I (5 cases) and type II (17 cases). Right lobectomy with right caudate lobectomy was performed in type IIIa (6 cases), left lobectomy with left caudate lobectomy in type IIIb (15 cases). Right lobectomy with whole caudate lobectomy (3 cases), left lobectomy with whole caudate lobectomy (9 cases), and quadrate lobectomy (2 cases) were undertaken in type IV. We successfully did SR and left lobectomy with whole caudate lobectomy in 2 patients (3%) who had suffered palliative biliary cancer resection and cholangiojejunostomy before. Eight patients (12%) had local resection of the tumor with Roux-en-Y hepaticojejunostomy reconstruction and intrahepatic bile ducts support. Two patients (3%) had palliative biliary drainage. Combined portal vein resection was performed in 13 (20%) patients and hepatic artery resection in 27 (40.3%). Twenty-four (35.8%) patients had no postoperative complications, and 20 (30.2%) patients developed major complications. Of the 20 patients with major complications 14 recovered; the remaining 6 patients died of liver-renal failure with other organ failure or of heart attack, intraabdominal bleeding, and gastrointestinal bleeding in 7, 12, 14, 42, 57, or 89 days after surgery. Thirty days operative mortality was 4.5%. The median survival of patients with curative resection was 16 months (ranging from 1 to 41 months), while the median survival with palliative operation was 7 months (ranging from 1 to 16 months).

CONCLUSIONS

Partial hepatectomy with skeletonization resection for hilar cholangiocarcinoma can be performed with acceptable morbidity and mortality. For curative treatment of hilar cholangiocarcinoma, Caudate lobectomy is always recommended in Bismuth type III/IV.

摘要

目的

总结作者经验并明确肝门部胆管癌骨骼化切除的肝部分切除术在治疗中的作用。

方法

1999年1月至2001年12月,我院67例患者接受了探查。回顾了这些患者的临床记录。

结果

65例(97%)患者接受了手术切除。49例(73%)患者行根治性切除[22例行骨骼化切除(SR),另外27例行SR联合肝部分切除术]。根据Bismuth-Corlett分类,肿瘤分为四型。I型(5例)和II型(17例)行SR。IIIa型(6例)行右半肝切除联合右尾状叶切除,IIIb型(15例)行左半肝切除联合左尾状叶切除。IV型行右半肝切除联合全尾状叶切除(3例)、左半肝切除联合全尾状叶切除(9例)及方叶切除(2例)。我们成功地为2例(3%)曾接受过姑息性胆管癌切除及胆管空肠吻合术的患者行了SR及左半肝切除联合全尾状叶切除。8例(12%)患者行肿瘤局部切除并Roux-en-Y肝管空肠吻合重建及肝内胆管支撑。2例(3%)患者行姑息性胆管引流。13例(20%)患者行门静脉联合切除,27例(40.3%)患者行肝动脉切除。24例(35.8%)患者无术后并发症,20例(30.2%)患者发生严重并发症。20例严重并发症患者中14例康复;其余6例患者分别于术后7、12、14、42、57或89天死于肝肾衰竭合并其他器官衰竭、心肌梗死、腹腔内出血及消化道出血。30天手术死亡率为4.5%。根治性切除患者的中位生存期为16个月(1至41个月),而姑息性手术患者的中位生存期为7个月(1至16个月)。

结论

肝门部胆管癌骨骼化切除的肝部分切除术可在可接受的发病率和死亡率下进行。对于肝门部胆管癌的根治性治疗,Bismuth III/IV型总是建议行尾状叶切除。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验